AR044175A1 - Compuestos de cefemo - Google Patents

Compuestos de cefemo

Info

Publication number
AR044175A1
AR044175A1 ARP040101534A ARP040101534A AR044175A1 AR 044175 A1 AR044175 A1 AR 044175A1 AR P040101534 A ARP040101534 A AR P040101534A AR P040101534 A ARP040101534 A AR P040101534A AR 044175 A1 AR044175 A1 AR 044175A1
Authority
AR
Argentina
Prior art keywords
amino
compound
formula
cefemo
compounds
Prior art date
Application number
ARP040101534A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co, Wakunaga Pharma Co Ltd filed Critical Fujisawa Pharmaceutical Co
Publication of AR044175A1 publication Critical patent/AR044175A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de la fórmula (1), en donde: R1 es alquilo inferior que puede tener sustituyente apropiados; R2 es amino, amino protegido o guanidino; R3 es carboxi o carboxi protegido; R4 es amino o amino protegido; y A es alquileno inferior, o una de sus sales farmacéuticamente aceptables. Un procedimiento para preparar un compuesto de la fórmula (1), y una composición farmacéutica que comprende un compuesto de la fórmula (1), en mezcla con un portador farmacéuticamente aceptable.
ARP040101534A 2003-05-16 2004-05-05 Compuestos de cefemo AR044175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003902380A AU2003902380A0 (en) 2003-05-16 2003-05-16 Cephem compounds

Publications (1)

Publication Number Publication Date
AR044175A1 true AR044175A1 (es) 2005-08-24

Family

ID=31501249

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101534A AR044175A1 (es) 2003-05-16 2004-05-05 Compuestos de cefemo

Country Status (5)

Country Link
US (1) US20050004094A1 (es)
AR (1) AR044175A1 (es)
AU (1) AU2003902380A0 (es)
TW (1) TW200500369A (es)
WO (1) WO2004101571A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4251873B2 (ja) * 2001-05-01 2009-04-08 アステラス製薬株式会社 セフェム化合物
BRPI0315188B8 (pt) * 2002-10-30 2021-05-25 Astellas Pharma Inc composto e composição farmacêutica
JP4643577B2 (ja) * 2003-09-18 2011-03-02 アステラス製薬株式会社 セフェム化合物
JP2009530228A (ja) * 2006-03-16 2009-08-27 アステラス製薬株式会社 セフェム化合物および抗菌薬としての利用
UA121298C2 (uk) 2013-03-15 2020-05-12 Мерк Шарп І Доум Корп. Антибіотична композиція на основі цефтолозану і тазобактаму
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US10214543B2 (en) 2014-12-30 2019-02-26 Merck Sharp & Dohme Corp. Synthesis of cephalosporin compounds
WO2017147462A1 (en) * 2016-02-24 2017-08-31 Greenwave Systems PTE Ltd. Motion sensor for occupancy detection and intrusion detection
US11745549B2 (en) * 2017-08-21 2023-09-05 Sram. Llc Pressure sensing assembly for a bicycle wheel
CN120987935B (zh) * 2025-08-04 2026-02-06 齐鲁安替制药有限公司 一种头孢洛扎中间体的制备工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194432A (en) * 1985-11-22 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5210080A (en) * 1987-09-07 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
IE63094B1 (en) * 1987-09-14 1995-03-22 Fujisawa Pharmaceutical Co Cephem compound and a process for preparation thereof
US5173485A (en) * 1988-03-09 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Cephem compounds
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
US5215982A (en) * 1989-11-10 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
KR910015587A (ko) * 1990-02-27 1991-09-30 후지사와 토모키치로 세펨 화합물
JPH09110877A (ja) * 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
AUPN955596A0 (en) * 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
JP4251873B2 (ja) * 2001-05-01 2009-04-08 アステラス製薬株式会社 セフェム化合物
BRPI0315188B8 (pt) * 2002-10-30 2021-05-25 Astellas Pharma Inc composto e composição farmacêutica
JP4643577B2 (ja) * 2003-09-18 2011-03-02 アステラス製薬株式会社 セフェム化合物

Also Published As

Publication number Publication date
US20050004094A1 (en) 2005-01-06
TW200500369A (en) 2005-01-01
WO2004101571A1 (en) 2004-11-25
AU2003902380A0 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
ATE297203T1 (de) Antithrombotische mitteln
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
ATE306261T1 (de) Antithrombosemittel
TW200730540A (en) Novel peptide compounds
DK1265606T3 (da) Celleadhæsionsinhibitorer
ATE273305T1 (de) Thrombin-inhibitoren
SE0202463D0 (sv) Novel compounds
MXPA03011981A (es) 3-fluoruro-pirrolidinas como agentes antidiabeticos.
MXPA05009668A (es) Proceso libre de azida para preparar compuestos de 1,2-diamino.
AR045768A1 (es) Compuestos de cefem y sus sales farmaceuticamente aceptables
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
AR044175A1 (es) Compuestos de cefemo
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
WO2004014868A3 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
DK0686142T3 (da) Polyaminderivater som radioprotektive midler
AR033300A1 (es) Compuestos de cefem
DE60330758D1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
ATE308540T1 (de) Antithrombosemittel
TW200505446A (en) Inhibitor of cox
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
DE69827614D1 (de) Chinoxalindionen
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие

Legal Events

Date Code Title Description
FB Suspension of granting procedure